Event will be May 17-18 in Costa Mesa.
Scientists, advocates, health care providers, policymakers and community members will share recent advances in breast cancer prevention, detection, treatment and survivorship research and look ahead to new research directions.
The symposium, “From Research to Action: Two Decades of Change,” commemorates 20 years of work by the California Breast Cancer Research Program (CBCRP), which is administered by the University of California Office of the President on behalf of the state of California. Since its establishment in 1993 by the state Legislature, the CBCRP has been hailed for its innovative research and for involving advocates and community members in charting research strategies.
“The symposium is an opportunity for people who are affected by breast cancer to meet with the experts who are working on ways to halt the disease,” said Mhel Kavanaugh-Lynch, M.D., M.P.H., director of the CBCRP. “Among the goals is to give everyone a good understanding of the interactions between research and policy, how each drives the other, and the implications for future breast cancer research, prevention and care.”
Symposium highlights include:
- Sessions on the environmental impacts on breast cancer risk, including discussion of a recent federal report, “Breast Cancer and the Environment: Prioritizing Prevention,” which outlines a new path for future research. A panel to discuss the impact of the report on communities will include division directors of the National Institute of Environmental Health Sciences and the National Cancer Institute.
- A program on the “Role of Research in Setting Breast Cancer Policy.” Panelists will discuss how laws on genetic patents and privacy and health care reform will shape team research, patient recruitment and health care in the years ahead.
- “Breast Cancer 101,” a workshop on the fundamentals of breast cancer basic science and clinical outcomes for symposium attendees who do not have a background in scientific research.
In addition to some of the top breast cancer researchers in the state, keynote speakers will be:
- Susan Love, M.D., president of the Dr. Susan Love Research Foundation, whose address is titled “Pushing the Envelope: 20 Years of Pioneering Breast Cancer Research in California.”
- Dennis Slamon, M.D., Ph.D, director of UCLA Clinical/Translational Research and the Revlon/UCLA Women’s Cancer Research Program at the JonssonComprehensive Cancer Center. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the breast cancer drug Herceptin.
The symposium will take place at the Hilton Orange County/Costa Mesa. The registration fee is $25, and the deadline to register is April 26. To register go to: http://cbcrp.org/symposium/registration2013/choose.asp
For more information about the symposium, visit: http://cbcrp.org/symposium
About the California Breast Cancer Research Program
The mission of the California Breast Cancer Research Program (CBCRP) is to eliminate breast cancer by leading innovation in research, communication and collaboration in the California scientific and lay communities.
Created by the state Legislature in 1993, the CBCRP is the largest state-funded breast cancer research program in the nation and is administered by the University of California Office of the President. To date, the CBCRP has awarded 939 grants to 107 scientific institutions and community entities, totaling more than $230 million for research in California to prevent, treat and cure breast cancer. Grants from the CBCRP fill gaps not traditionally funded by other research programs to jump-start new areas of investigation that push the boundaries of research and foster new collaborations.
The CBCRP is funded through the voluntary tax check-off program on personal income tax form 540, a portion of the state tobacco tax and individual contributions. For more information, visit cabreastcancer.org.